Table 2.
AMACR/HMWCK and P63 status | No of cases (n=80) | Percentage | |
---|---|---|---|
Benign (40) | Malignant (40) | ||
AMACR+/HMWCK and P63+ | 0 | 0 | 0 |
AMACR+/HMWCK and P63- | 0 | 36 | 45 |
AMACR-/HMWCK and P63+ | 40 | 0 | 50 |
AMACR-/HMWCK and P63- | 0 | 4 | 5 |
Total | 40 | 40 | 100 |
AMACR/HMWCK and P63 status | No of cases (n=80) | Percentage | |
---|---|---|---|
Benign (40) | Malignant (40) | ||
AMACR+/HMWCK and P63+ | 0 | 0 | 0 |
AMACR+/HMWCK and P63- | 0 | 36 | 45 |
AMACR-/HMWCK and P63+ | 40 | 0 | 50 |
AMACR-/HMWCK and P63- | 0 | 4 | 5 |
Total | 40 | 40 | 100 |